|
[1]
|
Bingham III, C.O. (2002) The pathogenesis of rheumatoid arthritis: Pivotal cytokines involved in bone degradation and inflammation. The Journal of Rheumatology, 29, 3-9.
|
|
[2]
|
Nanjundaiah, S.M., Astry, B. and Moudgil, K.D. (2013) Mediators of inflammation-induced bone damage in arthritis and their control by herbal products. Evidence-Based Complementary and Alternative Medicine, 2013, 1-20.
|
|
[3]
|
Ziche, M. and Morbidelli, L. (2000) Nitric oxide and angiogenesis. Journal of Neuro-Oncology, 50, 139-148.
doi:10.1155/2013/518094
|
|
[4]
|
Cooke, J.P. and Losordo, D.W. (2002) Nitric oxide and angiogenesis. Circulation, 105, 2133-2135.
doi:10.1161/01.CIR.0000014928.45119.73
|
|
[5]
|
Tamura, T., Nakanishi, T., Kimura, Y., Hattori, T., Sasaki, K., Norimatsu, H., Takahashi, K. and Takigawa, M. (1996) Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology, 137, 3729-3737. doi:10.1210/en.137.9.3729
|
|
[6]
|
Moulton, K.S., Heller, E., Konerding, M.A., Flynn, E., Palinski, W. and Folkman, J. (1999) Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation, 99, 1726-1732.
doi:10.1161/01.CIR.99.13.1726
|
|
[7]
|
Matsunaga, T., Weihrauch, D.W., Moniz, M.C., Tessmer, J., Warltier, D.C. and Chilian, W.M. (2002) Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation, 105, 2185-2191.
doi:10.1161/01.CIR.0000015856.84385.E9
|
|
[8]
|
Chun, Y.J., Kim, M.Y. and Guengerich, F.P. (1999) Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochemical and Biophysical Research Communications, 262, 20-24. doi:10.1006/bbrc.1999.1152
|
|
[9]
|
Orsini, F., Pelizzoni, F., Verotta, L., Aburjai, T. and Rogers, C.B. (1997) Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-beta-D-glucopyranoside and related compounds. Journal of Natural Products, 60, 1082-1087. doi:10.1021/np970069t
|
|
[10]
|
Arichi, H., Kimura, Y., Okuda, H., Baba, K., Kozawa, M. and Arichi, S. (1982) Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chemical Pharmaceutical Bulletin, 30, 1766-1770. doi:10.1248/cpb.30.1766
|
|
[11]
|
Goldberg, D.M. (1996) More on antioxidant activity of resveratrol in red wine. Clinical Chemistry, 42, 113-114.
|
|
[12]
|
Pace-Asciak, C.R., Hahn, S., Diamandis, E.P., Soleas, G. and Goldberg, D.M. (1995) The red wine phenolics transresveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clinica Chimica Acta, 235, 207-219. doi:10.1016/0009-8981(95)06045-1
|
|
[13]
|
Inamori, Y., Inamori, Y., Kubo, M., Tsujibo, H., Ogawa, M., Saito, Y., Miki, Y. and Takemura, S. (1987) The ichthyotoxicity and coronary vasodilator action of 3,3’-dihydroxy-alpha,beta-diethylstilbene. Chemical and Pharmaceutical Bulletin, 35, 887-890. doi:10.1248/cpb.35.887
|
|
[14]
|
Tang, L.L., Gao, J.S., Chen, X.R. and Xie, X. (2006) Inhibitory effect of resveratrol on the proliferation of synoviocytes in rheumatoid arthritis and its mechanism in vitro. Zhong Nan Da Xue Xue Bao Yi Xue Ban, 31, 528-533.
|
|
[15]
|
Elmali, N., Baysal, O., Harma, A., Esenkaya, I. and Mizrak, B. (2007) Effects of resveratrol in inflammatory arthritis. Inflammation, 30, 1-6.
doi:10.1007/s10753-006-9012-0
|
|
[16]
|
Bi, X.L., Yang, J.Y., Dong, Y.X., Wang, J.M., Cui, Y.H., Ikeshima, T., Zhao, Y.Q. and Wu, C.F. (2005) Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. International Immunopharmacology, 5, 185-193.
doi:10.1016/j.intimp.2004.08.008
|
|
[17]
|
Tseng, S.H., Lin, S.M., Chen, J.C., Su, Y.H., Huang, H.Y., Chen, C.K., Lin, P.Y. and Chen, Y. (2004) Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Experimental Therapeutic Preclinical Pharmacology, 10, 2190-2202.
|
|
[18]
|
Ghai, G., Chen, K.Y., Rosen, R.T., Wang, M., Telang, N., Lipkin, M. and Ho, C.-T. (2004) Resveratrol analogs for prevention of disease, US Patent 6790869. The State University of New Jersey, Rutgers.
|
|
[19]
|
Pettit, G.R., Grealish, M.P., Jung, M.K., Hamel, E., Pettit, R K., Chapuis, J.C. and Schmidt, J.M. (2002) Antineoplastic agents. 465. Structural modification of resveratrol: Sodium resverastatin phosphate. Journal of Medicinal Chemistry, 45, 2534-2542. doi:10.1021/jm010119y
|
|
[20]
|
Ohyama, M., Ohyama, M., Tanaka, T., Ito, T., Iinuma, M., Bastow, K.F. and Lee, K.H. (1999) Antitumor agents 200. Cytotoxicity of naturally occurring resveratrol oligomers and their acetate derivatives. Bioorganic Medicinal Chemistry Letters, 9, 3057-3060.
doi:10.1016/S0960-894X(99)00520-X
|
|
[21]
|
Gosslau A., Chen, M., Ho, C.T. and Chen, K.Y. (2005) A methoxy derivative of resveratrol analogue selectively induced activation of the mitochondrial apoptotic pathway in transformed fibroblasts. British Journal of Cancer, 92, 513-521.
|
|
[22]
|
Gosslau, A., Pabbaraja, S., Knapp, S. and Chen, K.Y. (2008) Trans-and cis-stilbene polyphenols induced rapid perinuclear mitochondrial clustering and p53-independent apoptosis in cancer cells but not normal cells. European Journal of Pharmacology, 587, 25-34.
doi:10.1016/j.ejphar.2008.03.027
|
|
[23]
|
Takahashi, S., Uchiyama, T. and Toda, K. (2009) Differential effect of resveratrol on nitric oxide production in endothelial f-2 cells. Biological and Pharmaceutical Bulletin, 32, 1840-1843. doi:10.1248/bpb.32.1840
|
|
[24]
|
Cho, D.I., Koo, N.Y., Chung, W.J., Kim, T.S., Ryu, S.Y., Im, S.Y. and Kim, K.M. (2002) Effects of resveratrol-related hydroxystilbenes on the nitric oxide production in macrophage cells: Structural requirements and mechanism of action. Life Sciences, 71, 2071-2082.
doi:10.1016/S0024-3205(02)01971-9
|
|
[25]
|
FitzGerald, O., Soden, M., Yanni, G., Robinson, R. and Bresnihan, B. (1991) Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 50, 792-796. doi:10.1136/ard.50.11.792
|
|
[26]
|
Ceponis, A., Konttinen, Y.T., Imai, S. Tamulaitiene, M., Li, T.F., Xu, J.W., Hietanen, J., Santavirta, S. and Fassbender, H.G. (1998) Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: A comparative quantitative morphometric study. British Journal of Rheumatology, 37, 170-178.
doi:10.1093/rheumatology/37.2.170
|
|
[27]
|
Walsh, D.A., Wade, M., Mapp, P.I. and Blake, D.R. (1998) Focally regulated endothelial proliferation and cell death in human synovium. American Journal of Pathology, 152, 691-702.
|
|
[28]
|
Cao, Y., FU, Z.-D., Wang, F., Liu, H.-Y. and Han, R. (2005) Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants. Journal of Asian Natural Products Research, 7, 205-213.
doi:10.1080/10286020410001690190
|
|
[29]
|
Gentilli, M., Mazoit, J.X., Bouaziz, H., Fletcher, D., Casper, R.F., Benhamou, D. and Savouret, J.-F. (2001) Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw. Life Science, 68, 1317-1321.
doi:10.1016/S0024-3205(00)01018-3
|